Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $55
Exelixis, Inc.
Exelixis, Inc. EXEL | 0.00 |
Citizens analyst Silvan Turkcan maintains Exelixis (NASDAQ:
EXEL) with a Market Outperform and raises the price target from $50 to $55.